Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/12/2011
PIL Humatrope 6mg, 12mg, or 24mg powder and solvent for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 08/02/2011 and displayed until 13/12/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 24/04/2009 and displayed until 08/02/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 22/05/2008 and displayed until 24/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 30/10/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to how to administer the medicine
  • Change to storage instructions
  • Change of special precautions for disposal
  • Change to MA holder contact details
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 26/10/2007 and displayed until 30/10/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to how to administer the medicine
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to drug interactions
  • Change of special precautions for disposal
  • Change to MA holder contact details
  • Change to date of revision
  • Pending awaiting re-submission
Updated on 10/08/2006 and displayed until 26/10/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to date of revision
Updated on 05/10/2001 and displayed until 10/08/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 22/06/2001 and displayed until 05/10/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 12/04/2000 and displayed until 22/06/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 18/01/2000 and displayed until 12/04/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  somatropin